In experimental and clinical arthritis, TREM-1 is well known to mediate the release of proinflammatory cytokines and chemokines, including CSF-1 [27,30,62,63,64], that are all implicated in RA disease pathogenesis [65]. This evidence concerns the gene CSF1 and rheumatoid arthritis.